Unveiling the map to designing treatments for dengue and zika virusesApril 25, 2019
Scientists from the Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS), together with scientists from Duke-NUS Medical School and A*STAR’s Bioinformatics Institute (BII), have mapped out the structures of four dengue and four Zika viruses.
The research focuses on understanding the genetic materials and shapes of these viruses, as well as their corresponding functions. Consequently, understanding their biology enables scientists to design better drugs and treatments. Mosquito-borne infections are common and deadly in tropical and subtropical regions around the world. Estimates suggest up to 700 million infections and over one million deaths are caused by a variety of mosquito-borne viruses yearly. One major class of mosquito-borne viruses are the Flaviviruses, which include the dengue and Zika viruses. Dengue is a well-known virus which affects more than 390 million people around the world. Singapore is one of the major hotspots of dengue infection. Every year, 2,000 to 3,000 people are affected by dengue in Singapore. Whilst most of these cases are fairly mild, dengue-associate deaths still occur each year. While the Zika virus has generally limited severity in healthy adults, there has been greater public interest due to the Zika epidemic from 2015 to 2016, and reports of adverse health effects observed in South America. Four dengue and four Zika virus strains Using structure probing, the scientists mapped the long genetic materials of four dengue and four Zika virus strains. The research studied the viruses’ activities and vital parts to identify portions of the viruses’ genetic materials that could be targeted for treatments. Through the identification of the common shapes and structures of the viruses, scientist will be able to design new drug treatments to target these areas. Dr Wan Yue, Principal Investigator at A*STAR’s GIS and lead author of the study said, “Mapping the shapes and structures of the dengue and Zika viruses will boost understanding of their biology, and contribute significantly towards designing drug treatments targeted at these viruses.” “Moving ahead, additional research needs to be performed to better understand how the viruses’ structural mutations reduce their effect. It will also identify the roles that different structures play during their lifecycles,” she added. Dr Roland G. Huber, Assistant Principal Investigator at A*STAR’s BII, said, “Understanding the structures of these viruses required us to develop innovative techniques to find synergies in the vast amount of data generated for this study. We developed new tools that will allow us to better understand the architecture of these and other viruses in the future. |
EXPLORE FURTHER
Debunking common myths about dengue: What you need to knowUnderstanding dengue myths can help protect your health effectively
|
When dengue lasts beyond the fever: The hidden impact of post-dengue syndromeSevere dengue can severely affect your health, with post-dengue syndrome lingering for months
|
Takeda dengue vaccine candidate show long term safety results in pivotal phase 3 efficacy trialTAK-003 is based on a live-attenuated dengue serotype 2 virus
|
Dengue patrol reaches 795,000 through ground and digital activitiesStudents unite to combat dengue through innovative initiatives
|